227 related articles for article (PubMed ID: 8302461)
1. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
[TBL] [Abstract][Full Text] [Related]
2. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
Wright S; Steinwandel U; Ferrari P
Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
[TBL] [Abstract][Full Text] [Related]
3. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
4. Citrate anticoagulation and dialysate with reduced buffer content in chronic hemodialysis.
van der Meulen J; Janssen MJ; Langendijk PN; Bouman AA; Oe PL
Clin Nephrol; 1992 Jan; 37(1):36-41. PubMed ID: 1541063
[TBL] [Abstract][Full Text] [Related]
5. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
[TBL] [Abstract][Full Text] [Related]
6. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
7. Citrate haemodialysis.
Faber LM; de Vries PM; Oe PL; van der Meulen J; Donker AJ
Neth J Med; 1990 Dec; 37(5-6):219-24. PubMed ID: 2074914
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
[TBL] [Abstract][Full Text] [Related]
9. Regional citrate anticoagulation during hemodialysis: a simplified procedure using Duocart biofiltration.
Ridel C; Mercadal L; Béné B; Hamani A; Deray G; Petitclerc T
Blood Purif; 2005; 23(6):473-80. PubMed ID: 16282684
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
11. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
13. [Regional anticoagulation with citrate in hemodialysis in patients with a high risk for hemorrhage].
Perdrix JP; Lepape A; Gronlier T; Grozel JM; Banssillon V
Ann Fr Anesth Reanim; 1988; 7(1):31-5. PubMed ID: 3348512
[TBL] [Abstract][Full Text] [Related]
14. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure.
Morgera S; Scholle C; Melzer C; Slowinski T; Liefeld L; Baumann G; Peters H; Neumayer HH
Nephron Clin Pract; 2004; 98(1):c35-40. PubMed ID: 15361702
[TBL] [Abstract][Full Text] [Related]
15. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
[TBL] [Abstract][Full Text] [Related]
16. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
Evenepoel P; Maes B; Vanwalleghem J; Kuypers D; Messiaen T; Vanrenterghem Y
Am J Kidney Dis; 2002 Feb; 39(2):315-23. PubMed ID: 11840372
[TBL] [Abstract][Full Text] [Related]
17. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
[TBL] [Abstract][Full Text] [Related]
18. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis.
Ljungberg B; Blombäck M; Johnsson H; Lins LE
Clin Nephrol; 1987 Jan; 27(1):31-5. PubMed ID: 3815906
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation during haemodialysis using a citrate-enriched dialysate: a feasibility study.
Cheng YL; Yu AW; Tsang KY; Shah DH; Kjellstrand CM; Wong SM; Lau WY; Hau LM; Ing TS
Nephrol Dial Transplant; 2011 Feb; 26(2):641-6. PubMed ID: 20615906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
